...
首页> 外文期刊>Antiviral Research >3-(imidazo[1,2-a:5,4-b ']dipyridin-2-yl)aniline inhibits pestivirus replication by targeting a hot spot drug binding pocket in the RNA-dependent RNA polymerase
【24h】

3-(imidazo[1,2-a:5,4-b ']dipyridin-2-yl)aniline inhibits pestivirus replication by targeting a hot spot drug binding pocket in the RNA-dependent RNA polymerase

机译:3-(咪唑并[1,2-a:5,4-b']双吡啶-2-基)苯胺通过靶向RNA依赖性RNA聚合酶中的热点药物结合袋来抑制瘟病毒复制

获取原文
获取原文并翻译 | 示例
           

摘要

The compound 3-(imidazo[1,2-a:5,4-b']dipyridin-2-yl)aniline (CF02334) was identified as a selective inhibitor of the cytopathic effect (CPE) caused by bovine viral diarrhea virus (BVDV) in a virus-cell-based assay. The EC50-values for inhibition of CPE, viral RNA synthesis and the production of infectious virus progeny were 13.0 +/- 0.6 mu M, 2.6 +/- 0.9 mu M and 17.8 +/- 0.6 mu M, respectively. CF02334 was found to be inactive in the hepatitis C subgenomic replicon system. CF02334-resistant BVDV was obtained and was found to carry the N264D mutation in the viral RNA-dependent RNA polymerase (RdRp). Molecular modeling revealed that N264D is located in a small cavity near the fingertip domain of the pestivirus polymerase. CF02334-resistant BVDV was proven to be cross-resistant to BPIP, AG110 and LZ37, inhibitors that have previously been described to target the same region of the BVDV RdRp. CF02334 did not inhibit the in vitro activity of recombinant BVDV RdRp, but did inhibit the activity of BVDV replication complexes. Taken together, these observations indicate that CF02334 likely interacts with the fingertip of the pestivirus RdRp at the same position as BPIP, AG110 and 1237, which marks this region of the viral polymerase as a "hot spot" for inhibition of pestivirus replication. (C) 2016 Elsevier B.V. All rights reserved.
机译:化合物3-(咪唑并[1,2-a:5,4-b']双吡啶-2-基)苯胺(CF02334)被鉴定为牛病毒性腹泻病毒(CPE)引起的细胞病变效应(CPE)的选择性抑制剂。 BVDV)。抑制CPE,病毒RNA合成和感染性病毒后代的EC50值分别为13.0 +/- 0.6μM,2.6 +/- 0.9μM和17.8 +/- 0.6μM。发现CF02334在丙型肝炎亚基因组复制子系统中无效。获得了抗CF02334的BVDV,并发现其在病毒RNA依赖性RNA聚合酶(RdRp)中带有N264D突变。分子建模表明,N264D位于瘟病毒聚合酶指尖结构域附近的小腔中。耐CF02334的BVDV已被证明对BPIP,AG110和LZ37具有交叉抗性,先前已描述过该抑制剂靶向BVDV RdRp的相同区域。 CF02334不会抑制重组BVDV RdRp的体外活性,但会抑制BVDV复制复合物的活性。综上所述,这些观察结果表明CF02334可能在与BPIP,AG110和1237相同的位置与瘟病毒RdRp的指尖相互作用,这标志着病毒聚合酶的这一区域是抑制瘟病毒复制的“热点”。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号